Supriya Lifescience Limited IPO: Issue Price, Listing Gain and Share Price Now
Supriya Lifescience Limited listed on 28-Dec-2021 at ₹390.35 against an issue price of ₹274 , a listing gain of +42.46%. It last traded at ₹812.65. This page is the record of that issue and what has happened to it since — reported figures only.
Supriya Lifescience Limited IPO: listing gain and return since
| Measure | Value |
|---|---|
| Issue price | ₹274 |
| Listing price (listing-day close) | ₹390.35 |
| Listing gain | +42.46% |
| Price now | ₹812.65 |
| Change from issue price | +196.59% |
| Change from listing-day close | +108.18% |
The two changes above answer different questions and are routinely opposite in sign. The change from the issue price is what an allottee has made. The change from the listing-day close is what somebody who bought on the first day has made.
Supriya Lifescience Limited IPO details
| Issue term | Detail |
|---|---|
| Issue price (upper band) | ₹274 |
| Issue size | ₹700 Cr |
| Fresh issue | ₹200 Cr |
| Offer for sale | ₹500 Cr |
| Issue opened | 16-Dec-2021 |
| Issue closed | 20-Dec-2021 |
| Listed on | 28-Dec-2021 |
| Exchange | BSE, NSE |
| Segment | Mainboard |
| Lead managers | Axis Capital (left lead) |
How the Supriya Lifescience Limited IPO was subscribed
| Category | Subscription |
|---|---|
| QIB | 31.83x |
| NII | 161.22x |
| Retail | 56.01x |
| Total | 71.51x |
Supriya Lifescience Limited today
| Figure | Value |
|---|---|
| Sector | Pharmaceuticals |
Fundamentals are as of the desk's last harvest and move with the market.
- Supriya Lifescience Limited — full issue page: every stored figure, with its source.
- How many IPOs still trade above their issue price, corporate-action adjusted.
- The full IPO archive: listing gains by year, sector and issue size.
Automated data digest. This page is compiled automatically from exchange filings and public aggregator data. It is a record of reported figures — it is not research, not a recommendation, and not investment advice.
Grey Market Premium (GMP) is an unofficial, unregulated price quoted outside the exchanges. It is not a forecast of the listing price and is frequently wrong.
Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Investments in securities markets are subject to market risk; read all offer documents carefully before investing. Registration granted by SEBI and NISM certification in no way guarantee performance or assure returns.